SpechlerSJ, HunterJG, JonesKM. Randomized trial of medical versus surgical treatment for refractory heartburn. N Eng J Med2019; 381: 1513–23.
2.
EpsteinD, BojkeL, SculpherMJ. Laparoscopic fundoplication compared with medical management for gastro-oesophageal reflux disease: cost effectiveness study. BMJ2009; 339: b2576.
3.
GrantAM, BoachieC, CottonSC. Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicentre randomised trial (the REFLUX trial). Health Technol Assess2013; 17: 1–167.
4.
PauwelsA, BoecxstaensV, AndrewsCN. How to select patients for antireflux surgery? The ICARUS guidelines (international consensus regarding preoperative examinations and clinical characteristics assessment to select adult patients for antireflux surgery). Gut2019; 68: 1928–41.
RickenbacherN, KötterT, KochenMM. Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis. Surg Endosc2014; 28: 143–55.
7.
MooreM, AfanehC, BenhuriD. Gastroesophageal reflux disease: a review of surgical decision making. WJGS2016; 8: 77–83.
8.
GrantAM, WilemanSM, RamsayCR. Minimal access surgery compared with medical management for chronic gastro-oesophageal reflux disease: UK collaborative randomised trial. BMJ2008; 337: a2664.
9.
SandhuDS, FassR. Current trends in the management of gastroesophageal reflux disease. Gut Liver2018; 12: 7–16.
SmithL. Updated ACG guidelines for diagnosis and treatment of GERD. Am Fam Physician2005; 71: 2376–82.
12.
GralnekIM, DulaiGS, FennertyMB. Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials. Clin Gastroenterol Hepatol2006; 4: 1452–8.
13.
LiMJ, LiQ, SunM. Comparative effectiveness and acceptability of the FDA-licensed proton pump inhibitors for erosive esophagitis. A PRISMA-compliant network meta-analysis. Medicine (Baltimore)2017; 96: e8120.
14.
BadilloR, FrancisD. Diagnosis and treatment of gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther2014; 5: 105–12.
15.
WilemanSM, McCannS, GrantAM. Medical versus surgical management for gastrooesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev2010; 3: CD003243.
16.
LundelL, MiettinenP, MyrvoldHE. Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis. Br J Surg2007; 94: 198–203.
17.
PatelA, SayukGS, GyawaliCP. Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH-impedance monitoring. Neurogastroenterol Motil2016; 28: 1382–90.
